Intelligent Antibody Discovery


Molecular Templates Executes Licensing Transaction with Abeome Corporation

Molecular Templates, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), and Abeome Corporation, a monoclonal antibody discovery and development company, have entered into a worldwide licensing agreement in which Molecular Templates has licensed a high affinity antibody directed to PD-L1 and related intellectual property from Abeome.